SI-BONE Inc

SI-BONE Inc(SIBN)資訊與事件

$21.310

-0.168 (-0.79%)收盤時

SIBN 資訊

SIBN 事件

9/28 16:30

SI-Bone Receives FDA 510(k) Clearance for iFuse Granite Onyx System

SI-Bone announced FDA 510(k) clearance for the iFuse Granite Onyx System. This is SI-Bone's first product addressing the problem of compromised bone which is intended for use outside the pelvis, expanding the market opportunity for the company's 3D-printed bone integration platform.

8/3 17:00

Q2 Revenue of $56.0M Exceeds Consensus

Reports Q2 revenue $56.0M, consensus $55.4M. "Our accelerating growth and expanding profitability reinforces our conviction in the demand for our superior platform technologies and the significant runway ahead," said Laura Francis, CEO. "This quarter's record physician engagement reflects our strategy to develop unique procedural solutions for patients with compromised bone and underscores the meaningful market need we are addressing. We are excited about the upcoming third breakthrough device launch in the fourth quarter, a substantially improved reimbursement backdrop, and an expanding commercial reach. Together, these tailwinds position us to expand adoption, broaden patient access, and enter our next phase of strong, sustainable multi-year revenue growth."

8/3 17:00

Company Maintains FY26 Gross Margin Guidance at ~79%

The company is maintaining FY26 gross margin guidance at ~79%, and updating operating expenses guidance to now be ~12% compared to the prior guidance of ~12.5%.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易